These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10438060)

  • 1. Protection of swine from foot-and-mouth disease with one dose of an all-D retro peptide.
    Nargi F; Kramer E; Mezencio J; Zamparo J; Whetstone C; Van Regenmortel MH; Briand JP; Muller S; Brown F
    Vaccine; 1999 Jul; 17(22):2888-93. PubMed ID: 10438060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.
    Moraes MP; Mayr GA; Mason PW; Grubman MJ
    Vaccine; 2002 Feb; 20(11-12):1631-9. PubMed ID: 11858872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs.
    Mayr GA; O'Donnell V; Chinsangaram J; Mason PW; Grubman MJ
    Vaccine; 2001 Feb; 19(15-16):2152-62. PubMed ID: 11228388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection.
    Wong HT; Cheng SC; Chan EW; Sheng ZT; Yan WY; Zheng ZX; Xie Y
    Virology; 2000 Dec; 278(1):27-35. PubMed ID: 11112477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.
    Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S
    Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interspecies major histocompatibility complex-restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4.
    Blanco E; McCullough K; Summerfield A; Fiorini J; Andreu D; Chiva C; Borrás E; Barnett P; Sobrino F
    J Virol; 2000 May; 74(10):4902-7. PubMed ID: 10775633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase.
    Cedillo-Barrón L; Foster-Cuevas M; Belsham GJ; Lefèvre F; Parkhouse RME
    J Gen Virol; 2001 Jul; 82(Pt 7):1713-1724. PubMed ID: 11413383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the Relationship between immunity and the level of neutralizing antibodies in pigs vaccinated against foot-and-mouth disease (author's transl)].
    Bauer K; Lorenz RJ; Wittmann G
    Arch Virol; 1975; 49(4):349-57. PubMed ID: 174529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.
    Taboga O; Tami C; Carrillo E; Núñez JI; Rodríguez A; Saíz JC; Blanco E; Valero ML; Roig X; Camarero JA; Andreu D; Mateu MG; Giralt E; Domingo E; Sobrino F; Palma EL
    J Virol; 1997 Apr; 71(4):2606-14. PubMed ID: 9060612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies.
    Briand JP; Benkirane N; Guichard G; Newman JF; Van Regenmortel MH; Brown F; Muller S
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12545-50. PubMed ID: 9356486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
    Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
    Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to 146S particle, 12S protein subunit and isolated VP1 polypeptide of foot-and-mouth disease virus type Asia-1.
    Rao MG; Butchaiah G; Sen AK
    Vet Microbiol; 1994 Mar; 39(1-2):135-43. PubMed ID: 8203119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
    J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine.
    Pena L; Moraes MP; Koster M; Burrage T; Pacheco JM; Segundo FD; Grubman MJ
    Vaccine; 2008 Oct; 26(45):5689-99. PubMed ID: 18762225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
    Schutta C; Barrera J; Pisano M; Zsak L; Grubman MJ; Mayr GA; Moraes MP; Kamicker BJ; Brake DA; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2016 Jun; 34(27):3214-3220. PubMed ID: 26707216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a multiplex Luminex assay for detecting swine antibodies to structural and nonstructural proteins of foot-and-mouth disease virus in Taiwan.
    Chen TH; Lee F; Lin YL; Pan CH; Shih CN; Tseng CH; Tsai HJ
    J Microbiol Immunol Infect; 2016 Apr; 49(2):196-207. PubMed ID: 25074628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine.
    Moraes MP; Chinsangaram J; Brum MC; Grubman MJ
    Vaccine; 2003 Dec; 22(2):268-79. PubMed ID: 14615155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of foot-and-mouth disease virus and its capsid protein VP1 by bovine peripheral T lymphocytes.
    Garcia-Valcarcel M; Doel T; Collen T; Ryan M; Parkhouse RM
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():727-35. PubMed ID: 8627261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experiments on vaccination of pigs with ethyl-ethyleneimine (EEI) diethylaminoethyl dextran (DEAE-D) foot-and-mouth disease vaccines. Influence of route of inoculation and dose of antigen on the duration of immunity.
    Wittmann G; Bauer K; Mussgay M
    Arch Gesamte Virusforsch; 1972; 36(3):251-64. PubMed ID: 4336493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.